Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Menstruation irregular, Mood altered, Rash, Scratch
Clinical narrative: experienced menstrual cycle changes with a missed cycle; more tired than normal; showing signs of depression and forgetfulness; showing signs of depression and forgetfulness/Forgetting things more now; but very sleepy/Couldn't hardly wake up for 2 days; missed her cycle for 1 1/2 months, but now she has "; anxiety; stress; Her "hair was falling out; mood changes; Whole body rash; then began scratching a lot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team from a Pfizer-sponsored program. The reporter is the parent.  A 24 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 24 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Drug induced Lupus" (unspecified if ongoing), notes: daughter had other issues of drug induced Lupus after Minocycline; "allergic to anti-inflammatories" (unspecified if ongoing); "Pimples" (unspecified if ongoing), notes: took the Minocycline. The patient's concomitant medications were not reported. The following information was reported: MENSTRUAL DISORDER (non-serious), outcome "unknown", described as "experienced menstrual cycle changes with a missed cycle"; FATIGUE (non-serious), outcome "unknown", described as "more tired than normal"; DEPRESSION (non-serious), outcome "unknown", described as "showing signs of depression and forgetfulness"; MEMORY IMPAIRMENT (non-serious), outcome "unknown", described as "showing signs of depression and forgetfulness/Forgetting things more now"; SOMNOLENCE (non-serious), outcome "unknown", described as "but very sleepy/Couldn't hardly wake up for 2 days"; MENSTRUATION IRREGULAR (non-serious), outcome "unknown", described as "missed her cycle for 1 1/2 months, but now she has ""; ANXIETY (non-serious), outcome "unknown", described as "anxiety"; STRESS (non-serious), outcome "unknown", described as "stress"; ALOPECIA (non-serious), outcome "unknown", described as "Her "hair was falling out"; MOOD ALTERED (non-serious), outcome "unknown", described as "mood changes"; RASH (non-serious), outcome "unknown", described as "Whole body rash"; SCRATCH (non-serious), outcome "unknown", described as "then began scratching a lot". The event "her "hair was falling out" was evaluated at the physician office visit. Therapeutic measures were taken as a result of alopecia.  Additional information: The patient then ended up with Lupus and had to take Etodolac for 3 weeks and experienced side effects. The patient was then "rushed back in" and they put her on steroids although the provider really did not want to do this because of the side effects of the steroids, he advised that he had to. She was on steroids for 3.5 weeks. She gave up her whole senior year and was put on steroid for 2 years and monitored closely. Patient was suggested to consult with her doctor/healthcare provider about what the events experienced/are experiencing. Doctor mentioned they have been seeing a lot of that lately with all of the stress with Covid 19. Investigation Assessment: Not Provided.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.